chr3-52406826-T-G
Variant summary
Our verdict is Pathogenic. Variant got 11 ACMG points: 11P and 0B. PM2PP3PP5_Very_Strong
The NM_004656.4(BAP1):c.659+3A>C variant causes a splice region, intron change involving the alteration of a non-conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a benign outcome for this variant. 2/3 splice prediction tools predicting alterations to normal splicing. Variant has been reported in ClinVar as Likely pathogenic (★★).
Frequency
Consequence
NM_004656.4 splice_region, intron
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 11 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
BAP1 | NM_004656.4 | c.659+3A>C | splice_region_variant, intron_variant | Intron 8 of 16 | ENST00000460680.6 | NP_004647.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
BAP1 | ENST00000460680.6 | c.659+3A>C | splice_region_variant, intron_variant | Intron 8 of 16 | 1 | NM_004656.4 | ENSP00000417132.1 | |||
BAP1 | ENST00000296288.9 | c.659+3A>C | splice_region_variant, intron_variant | Intron 8 of 16 | 5 | ENSP00000296288.5 | ||||
BAP1 | ENST00000471532.5 | n.377A>C | non_coding_transcript_exon_variant | Exon 4 of 5 | 5 | |||||
BAP1 | ENST00000483984.5 | n.519A>C | non_coding_transcript_exon_variant | Exon 7 of 7 | 3 |
Frequencies
GnomAD3 genomes Cov.: 33
GnomAD4 exome Cov.: 32
GnomAD4 genome Cov.: 33
ClinVar
Submissions by phenotype
BAP1-related tumor predisposition syndrome Pathogenic:2
This sequence change falls in intron 8 of the BAP1 gene. It does not directly change the encoded amino acid sequence of the BAP1 protein. RNA analysis indicates that this variant induces altered splicing and may result in an absent or disrupted protein product. This variant is not present in population databases (gnomAD no frequency). This variant has been observed in individuals with clinical features of BAP1-related conditions (PMID: 28793149; Invitae). ClinVar contains an entry for this variant (Variation ID: 240065). Variants that disrupt the consensus splice site are a relatively common cause of aberrant splicing (PMID: 17576681, 9536098). Studies have shown that this variant results in retention of intron 8 and introduces a premature termination codon (PMID: 28793149). The resulting mRNA is expected to undergo nonsense-mediated decay. In summary, the currently available evidence indicates that the variant is pathogenic, but additional data are needed to prove that conclusively. Therefore, this variant has been classified as Likely Pathogenic. -
- -
Hereditary cancer-predisposing syndrome Pathogenic:1
The c.659+3A>C intronic variant results from an A to C substitution 3 nucleotides after coding exon 8 in the BAP1 gene. This nucleotide position is well conserved in available vertebrate species. In silico splice site analysis predicts that this alteration may weaken the native splice donor site. Research confirms that this alteration induces inclusion of intron 8 which is predicted to result in an abnormal protein or a transcript that is subject to nonsense-mediated mRNA decay (Haugh AM et al. JAMA Dermatol, 2017 Oct;153:999-1006). This alteration has been observed in at least one individual with a personal and/or family history that is consistent with BAP1-related disease (Ambry internal data). This alteration has also been reported in a family with several individuals who had multiple BAP1-related tumors and in which the variant segregated with disease (Haugh AM et al. JAMA Dermatol, 2017 Oct;153:999-1006). Based on the majority of available evidence to date, this variant is likely to be pathogenic. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at